🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 2 open label, randomized, active controlled, dose-ranging trial in ad...
Status
Recruiting
Location
Sierra Eye Associates
Start Date
2025-03-18
Trial ID
NCT06942520
Treatments Being Tested
RGX-314 is being developed as a novel one-time gene therapy for the treatme...
Status
Completed
Location
Retinal Consultants of Arizona
Start Date
2021-02-22
Trial ID
NCT04832724
Treatments Being Tested
This is a prospective study designed to evaluate the long-term safety and e...
Status
Enrolling By Invitation
Location
Retinal Research Institute, LLC
Start Date
2022-04-04
Trial ID
NCT05296447
Treatments Being Tested
Excessive vascular endothelial growth factor (VEGF) plays a key part in pro...
Status
Completed
Location
Santa Barbara location
Start Date
2017-03-29
Trial ID
NCT03066258
Treatments Being Tested
ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) i...
Status
Active Not Recruiting
Location
Barnet Dulaney Eye Center-Phoenix /ID# 256340
Start Date
2022-01-13
Trial ID
NCT05407636
Treatments Being Tested
ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time...
Status
Active Not Recruiting
Location
Retinal Research Institute /ID# 256019
Start Date
2020-12-29
Trial ID
NCT04704921
Treatments Being Tested
This interventional study is being conducted with an investigational gene t...
Status
Active Not Recruiting
Location
Retinal Research Institute /ID# 255925
Start Date
2020-08-25
Trial ID
NCT04514653
This is a prospective study designed to evaluate the long-term safety and e...
Status
Enrolling By Invitation
Location
Retinal Research Institute, LLC
Start Date
2021-12-20
Trial ID
NCT05210803
Treatments Being Tested
ABBV-RGX-314 is being developed as a novel, potential one-time gene therapy...
Status
Active Not Recruiting
Location
Retinal Research Institute, LLC
Start Date
2020-11-20
Trial ID
NCT04567550
Neovascular age-related macular degeneration (nAMD), also known as "wet" AM...
Status
Recruiting
Location
Barnet Dulaney Perkins Eye Centers /ID# 279265
Start Date
2025-11-05
Trial ID
NCT07007065
Treatments Being Tested